Department of Physiotherapy, Center of Health and Sport Sciences, Santa Catarina State University, Florianópolis, Brazil.
Disabil Rehabil. 2022 Jul;44(15):4096-4103. doi: 10.1080/09638288.2021.1897885. Epub 2021 Mar 21.
To evaluate the reliability and convergent validity of the Upper Limb Functional Test (ULIFT) in women after breast cancer surgery.
A cross-sectional study with 25 women (mean age 50 ± 7.3 years) with breast cancer submitted to a surgery intervention within a minimum period of three years. Intraclass correlation coefficients (ICCs) were calculated to assess the test-retest reliability. A Bland-Altman plot examined the agreement between the times to complete two tests. Validity was established by correlating the ULIFT and DASH total score. The receiver operating characteristic (ROC) curve was used to determine the cut-off point for ULIFT in order to discriminate patients with some level of upper limb dysfunction.
The ULIFT showed high reproducibility (ICC = 0.89; < 0.001), learning effect of 7.21%, and a moderate correlation with the DASH total score ( = 0.536; = 0.28; = 0.006). The standard error of measurement was 6.9 s and the smallest real difference was 19.1 s. The ROC curve indicated a cut-off point of 109.2 s (sensitivity = 68.7%; specificity = 77.8%; area under ROC curve = 0.77).
The ULIFT could be a valid and reliable test to assess upper limb functionality in patients submitted to breast cancer surgery.Implications for rehabilitationThe ULIFT is a reliable and valid test to assess upper limb function in women after breast cancer surgery, considering specifically the lifting and range of motion construct of unilateral upper limb function.The ULIFT could help identify those most at risk of developing upper limb dysfunction after breast cancer surgery and could benefit the follow-up of a postoperative rehabilitation program.Two ULIFTs should be performed in order to achieve patient's best performance.
评估乳腺癌手术后女性上肢功能测试(ULIFT)的可靠性和收敛效度。
一项横断面研究纳入了 25 名(平均年龄 50 ± 7.3 岁)乳腺癌手术后至少 3 年的女性。计算了组内相关系数(ICC)以评估测试-重测信度。Bland-Altman 图检查了两次完成测试的时间之间的一致性。通过 ULIFT 和 DASH 总分的相关性来确定有效性。使用受试者工作特征(ROC)曲线确定 ULIFT 的截断值,以区分上肢功能障碍程度不同的患者。
ULIFT 表现出高度的可重复性(ICC=0.89; <0.001)、7.21%的学习效应以及与 DASH 总分的中度相关性( =0.536; =0.28; =0.006)。测量误差的标准误为 6.9 秒,最小真实差异为 19.1 秒。ROC 曲线表明截断点为 109.2 秒(敏感性=68.7%;特异性=77.8%;ROC 曲线下面积=0.77)。
ULIFT 可作为一种有效且可靠的测试,用于评估乳腺癌手术后患者的上肢功能。
ULIFT 是一种可靠和有效的测试,可用于评估乳腺癌手术后女性的上肢功能,特别是单侧上肢功能的提升和运动范围结构。ULIFT 可以帮助识别乳腺癌手术后上肢功能障碍风险最高的患者,并有助于术后康复计划的随访。为了达到患者的最佳表现,应进行两次 ULIFT 测试。